4D Molecular Therapeutics CEO Sells Over $298K in Company Stock
![](https://industrytechinsights.com/wp-content/uploads/2024/07/4D-Molecular-Therapeutics-CEO-Sells-Over-298K-in-Company-Stock-300x169.png)
In a recent disclosure filing, 4D Molecular Therapeutics (NASDAQ: FDMT) reported that its Chief Executive Officer, David Kirn, sold company …
In a recent disclosure filing, 4D Molecular Therapeutics (NASDAQ: FDMT) reported that its Chief Executive Officer, David Kirn, sold company …